URSLINE CHARLES: Open Payments
NPI 1447745328 · RANCHO CORDOVA, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,842 in 173 payments from 20 companies in 2025. Trend: 2023 $425 · 2024 $2,622 · 2025 $3,842
Food & beverage: $3,835Education: $7
| Company | Payments | Amount |
|---|---|---|
| UCB, Inc. | 31 | $886 |
| ABBVIE INC. | 32 | $823 |
| Amgen Inc. | 23 | $524 |
| E.R. Squibb & Sons, L.L.C. | 26 | $327 |
| ANI Pharmaceuticals, Inc. | 12 | $280 |
| Novartis Pharmaceuticals Corporation | 11 | $207 |
| GlaxoSmithKline, LLC. | 12 | $137 |
| PFIZER INC. | 8 | $136 |
| Janssen Scientific Affairs, LLC | 1 | $134 |
| Mallinckrodt Hospital Products Inc. | 4 | $116 |
Products named: Bimzelx, SKYRIZI, Otezla, ORENCIA, PURIFIED CORTROPHIN GEL, RINVOQ, COSENTYX, TREMFYA.
Industry payments across CA — which companies pay providers there.
